Therapixel
FranceWho owns Therapixel?
Therapixel is a French HealthTech company, currently owned by Crédit Mutuel Equity since 2022 and 8 other investors.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
- ·Co-held by M Capital, Omnes Capital, Elaia Partners, Crédit Mutuel Equity, Crédit Mutuel Innovation, CapHorn, Turenne Groupe, Région Sud Investissement and Lazard Elaia Capital since 2018.
- ·9 distinct PE sponsors across ownership cycles.
Ownership history
9 ownership periods · co-invest detected
More from Lazard Elaia Capital Fund I
Other portfolio companies in the same fund.
USAMore PE-backed in Healthcare
Comparable healthcare deals from other GPs.
Questions
Who owns Therapixel?
Therapixel is currently owned by Crédit Mutuel Equity, Crédit Mutuel Innovation and 7 others, through Lazard Elaia Capital Fund I, since 2022.
When did Crédit Mutuel Equity and 8 others acquire Therapixel?
Crédit Mutuel Equity and 8 others acquired Therapixel in 2022.
Who has owned Therapixel over time?
Therapixel has been through 9 private-equity ownership periods: M Capital · via M Capital Venture · since 2018; Omnes Capital · via Omnes Real Tech 1 · since 2019; Elaia Partners · via Elaia Alpha II · since 2020; Crédit Mutuel Equity · via Crédit Mutuel Equity · since 2022; Crédit Mutuel Innovation · via Crédit Mutuel Innovation Evergreen Capital · since 2022; CapHorn · via CapHorn 2 · since 2022; Turenne Groupe · via Capital Santé 2 · since 2022; Région Sud Investissement · via RSI React Eu · since 2022; Lazard Elaia Capital · via Lazard Elaia Capital Fund I.